These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30827244)

  • 1. Acid Ceramidase: A Novel Therapeutic Target in Cancer.
    Vijayan Y; Lankadasari MB; Harikumar KB
    Curr Top Med Chem; 2019; 19(17):1512-1520. PubMed ID: 30827244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.
    Cho SM; Kwon HJ
    Arch Pharm Res; 2019 Mar; 42(3):232-243. PubMed ID: 30661200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acid ceramidase is upregulated in AML and represents a novel therapeutic target.
    Tan SF; Liu X; Fox TE; Barth BM; Sharma A; Turner SD; Awwad A; Dewey A; Doi K; Spitzer B; Shah MV; Morad SA; Desai D; Amin S; Zhu J; Liao J; Yun J; Kester M; Claxton DF; Wang HG; Cabot MC; Schuchman EH; Levine RL; Feith DJ; Loughran TP
    Oncotarget; 2016 Dec; 7(50):83208-83222. PubMed ID: 27825124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel off-target effect of tamoxifen--inhibition of acid ceramidase activity in cancer cells.
    Morad SA; Levin JC; Tan SF; Fox TE; Feith DJ; Cabot MC
    Biochim Biophys Acta; 2013 Dec; 1831(12):1657-64. PubMed ID: 23939396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid ceramidase inhibition sensitizes human colon cancer cells to oxaliplatin through downregulation of transglutaminase 2 and β1 integrin/FAK-mediated signalling.
    Klobučar M; Grbčić P; Pavelić SK; Jonjić N; Visentin S; Sedić M
    Biochem Biophys Res Commun; 2018 Sep; 503(2):843-848. PubMed ID: 29920241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Metallocenoylsphingosines as targeted ceramidase inhibitors: Syntheses and antitumoral effects.
    Rothemund M; Bär A; Klatt F; Weidler S; Köhler L; Unverzagt C; Kuhn CD; Schobert R
    Bioorg Chem; 2020 Apr; 97():103703. PubMed ID: 32143017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.
    Tan SF; Pearson JM; Feith DJ; Loughran TP
    Expert Opin Ther Targets; 2017 Jun; 21(6):583-590. PubMed ID: 28434262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy.
    Govindarajah N; Clifford R; Bowden D; Sutton PA; Parsons JL; Vimalachandran D
    Crit Rev Oncol Hematol; 2019 Jun; 138():104-111. PubMed ID: 31092365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A; de la Cueva A; Machado-Pinilla R; Rodriguez-Fanjul V; Gomez del Pulgar T; Cebrian A; Perona R; Lacal JC
    Curr Cancer Drug Targets; 2012 Jul; 12(6):617-24. PubMed ID: 22515519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines.
    Vethakanraj HS; Babu TA; Sudarsanan GB; Duraisamy PK; Ashok Kumar S
    Biochem Biophys Res Commun; 2015 Aug; 464(3):833-9. PubMed ID: 26188095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
    Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
    Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid ceramidase as a therapeutic target in metastatic prostate cancer.
    Camacho L; Meca-Cortés O; Abad JL; García S; Rubio N; Díaz A; Celià-Terrassa T; Cingolani F; Bermudo R; Fernández PL; Blanco J; Delgado A; Casas J; Fabriàs G; Thomson TM
    J Lipid Res; 2013 May; 54(5):1207-20. PubMed ID: 23423838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological inhibition of acid ceramidase prevents asymmetric cell division by neosis.
    White-Gilbertson S; Lu P; Norris JS; Voelkel-Johnson C
    J Lipid Res; 2019 Jul; 60(7):1225-1235. PubMed ID: 30988134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy.
    Liu X; Cheng JC; Turner LS; Elojeimy S; Beckham TH; Bielawska A; Keane TE; Hannun YA; Norris JS
    Expert Opin Ther Targets; 2009 Dec; 13(12):1449-58. PubMed ID: 19874262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid ceramidase inhibition: a novel target for cancer therapy.
    Liu X; Elojeimy S; Turner LS; Mahdy AE; Zeidan YH; Bielawska A; Bielawski J; Dong JY; El-Zawahry AM; Guo GW; Hannun YA; Holman DH; Rubinchik S; Szulc Z; Keane TE; Tavassoli M; Norris JS
    Front Biosci; 2008 Jan; 13():2293-8. PubMed ID: 17981711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen regulation of sphingolipid metabolism--Therapeutic implications.
    Morad SA; Cabot MC
    Biochim Biophys Acta; 2015 Sep; 1851(9):1134-45. PubMed ID: 25964209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramidases, roles in sphingolipid metabolism and in health and disease.
    Coant N; Sakamoto W; Mao C; Hannun YA
    Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altering the sphingosine-1-phosphate/ceramide balance: a promising approach for tumor therapy.
    Huwiler A; Pfeilschifter J
    Curr Pharm Des; 2006; 12(35):4625-35. PubMed ID: 17168766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose dependent actions of LCL521 on acid ceramidase and key sphingolipid metabolites.
    Bai A; Bielawska A; Rahmaniyan M; Kraveka JM; Bielawski J; Hannun YA
    Bioorg Med Chem; 2018 Dec; 26(23-24):6067-6075. PubMed ID: 30448190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.